These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21898342)

  • 1. Immune responses against domain I of β(2)-glycoprotein I are driven by conformational changes: domain I of β(2)-glycoprotein I harbors a cryptic immunogenic epitope.
    de Laat B; van Berkel M; Urbanus RT; Siregar B; de Groot PG; Gebbink MF; Maas C
    Arthritis Rheum; 2011 Dec; 63(12):3960-8. PubMed ID: 21898342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta2-glycoprotein I binds thrombin via exosite I and exosite II: anti-beta2-glycoprotein I antibodies potentiate the inhibitory effect of beta2-glycoprotein I on thrombin-mediated factor XIa generation.
    Rahgozar S; Yang Q; Giannakopoulos B; Yan X; Miyakis S; Krilis SA
    Arthritis Rheum; 2007 Feb; 56(2):605-13. PubMed ID: 17265495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.
    Takeya H; Mori T; Gabazza EC; Kuroda K; Deguchi H; Matsuura E; Ichikawa K; Koike T; Suzuki K
    J Clin Invest; 1997 May; 99(9):2260-8. PubMed ID: 9151800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant.
    Yasuda S; Atsumi T; Matsuura E; Kaihara K; Yamamoto D; Ichikawa K; Koike T
    Arthritis Rheum; 2005 Jan; 52(1):212-8. PubMed ID: 15641049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope studies with anti-beta 2-glycoprotein I antibodies from autoantibody and immunized sources.
    Reddel SW; Wang YX; Sheng YH; Krilis SA
    J Autoimmun; 2000 Sep; 15(2):91-6. PubMed ID: 10968891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular trafficking of beta2-glycoprotein I complexes with lipid vesicles in macrophages: implications on the development of antiphospholipid syndrome.
    Kajiwara T; Yasuda T; Matsuura E
    J Autoimmun; 2007; 29(2-3):164-73. PubMed ID: 17826950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta 2-Glycoprotein I and anti-beta 2-glycoprotein I antibodies: where are we now?
    Inanç M; Radway-Bright EL; Isenberg DA
    Br J Rheumatol; 1997 Dec; 36(12):1247-57. PubMed ID: 9448584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-beta2-glycoprotein I autoantibodies, in vitro thrombin generation, and the antiphospholipid syndrome.
    Hanly JG; Smith SA
    J Rheumatol; 2000 Sep; 27(9):2152-9. PubMed ID: 10990227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of β2-glycoprotein I (β2GPI) carbohydrate chains in the reactivity of anti-β2GPI antibodies from patients with primary antiphospholipid syndrome and in the activation and differentiation of U937 cells.
    Hernández-Ramírez DF; Olivares-Martínez E; Núñez-Álvarez CA; Chavelas EA; García-Hernández E; Gómez-Hernández G; Llorente L; Cabral AR
    Biochem Biophys Res Commun; 2014 Oct; 453(1):94-100. PubMed ID: 25256745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein C.
    de Laat B; Eckmann CM; van Schagen M; Meijer AB; Mertens K; van Mourik JA
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):757-64. PubMed ID: 19002041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant domain V of β2-glycoprotein I inhibits the formation of a 7-ketocholesteryl-9-carboxynonanoate and β2-glycoprotein I complex.
    Zhang Y; Li W; Chi Y; Wang R; Wang D; Zhang F; Liu Z; Matsuura E; Liu Q
    J Biochem; 2011 Jan; 149(1):35-42. PubMed ID: 20876187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of dilute Russell's viper venom time to detect autoantibodies against beta 2-glycoprotein I which express anticoagulant activity in the presence but not in the absence of exogenous phospholipids.
    Pengo V; Balestrieri G; Tincani A; Spatola L; Biasiolo A; Brocco T
    Thromb Haemost; 1997 Jan; 77(1):123-6. PubMed ID: 9031461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of giant phospholipid vesicles containing cardiolipin and cholesterol with beta2-glycoprotein-I and anti-beta2-glycoprotein-I antibodies.
    Ambrozic A; Cucnik S; Tomsic N; Urbanija J; Lokar M; Babnik B; Rozman B; Iglic A; Kralj-Iglic V
    Autoimmun Rev; 2006 Nov; 6(1):10-5. PubMed ID: 17110310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticardiolipin antibodies in NZW x BXSB F1 mice. A model of antiphospholipid syndrome.
    Hashimoto Y; Kawamura M; Ichikawa K; Suzuki T; Sumida T; Yoshida S; Matsuura E; Ikehara S; Koike T
    J Immunol; 1992 Aug; 149(3):1063-8. PubMed ID: 1634762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with atherosclerotic syndrome, negative in anti-cardiolipin assays, make IgA autoantibodies that preferentially target domain 4 of beta2-GPI.
    Iverson GM; von Mühlen CA; Staub HL; Lassen AJ; Binder W; Norman GL
    J Autoimmun; 2006 Dec; 27(4):266-71. PubMed ID: 17081732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous recognition of beta 2-glycoprotein I by antibodies from antiphospholipid syndrome patients.
    Guerin J; Sim R; Yu BB; Ferluga J; Feighery C; Jackson J
    Thromb Haemost; 2000 Sep; 84(3):374-80. PubMed ID: 11019958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome.
    Agar C; van Os GM; Mörgelin M; Sprenger RR; Marquart JA; Urbanus RT; Derksen RH; Meijers JC; de Groot PG
    Blood; 2010 Aug; 116(8):1336-43. PubMed ID: 20462962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of anti-β2 -glycoprotein I autoantibodies in mice by protein H of Streptococcus pyogenes.
    van Os GM; Meijers JC; Agar Ç; Seron MV; Marquart JA; Åkesson P; Urbanus RT; Derksen RH; Herwald H; Mörgelin M; D E Groot PG
    J Thromb Haemost; 2011 Dec; 9(12):2447-56. PubMed ID: 21985124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of antiphospholipid antibodies on beta(2) glycoprotein I-phospholipid Interaction.
    Gharavi AE; Cucurull E; Tang H; Silver RM; Branch DW
    Am J Reprod Immunol; 1998 May; 39(5):310-5. PubMed ID: 9602248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.